Literature DB >> 14523054

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease.

Maura Heverin1, Nenad Bogdanovic, Dieter Lütjohann, Thomas Bayer, Irina Pikuleva, Lionel Bretillon, Ulf Diczfalusy, Bengt Winblad, Ingemar Björkhem.   

Abstract

24S-hydroxycholesterol is a side-chain oxidized oxysterol formed in the brain that is continuously crossing the blood-brain barrier to reach the circulation. There may be an opposite flux of 27-hydroxycholesterol, which is formed to a lower extent in the brain than in most other organs. Here we measured cholesterol, lathosterol, 24S- and 27-hydroxycholesterol, and plant sterols in four different brain areas of deceased Alzheimer's disease (AD) patients and controls. 24S-hydroxycholesterol was decreased and 27-hydroxycholesterol increased in all the brain samples from the AD patients. The difference was statistically significant in four of the eight comparisons. The ratio of 27-hydroxycholesterol to 24S-hydroxycholesterol was significantly increased in all brain areas of the AD patients and also in the brains of aged mice expressing the Swedish Alzheimer mutation APP751. Cholesterol 24S-hydroxylase and 27-hydroxylase protein was not significantly different between AD patients and controls. A high correlation was observed between the levels of 24S-hydroxycholesterol and lathosterol in the frontal cortex of the AD patients but not in the controls. Most probably the high levels of 27-hydroxycholesterol are due to increased influx of this steroid over the blood-brain barrier and the lower levels of 24S-hydroxycholesterol to decreased production. The high correlation between lathosterol and 24-hydroxycholesterol is consistent with a close coupling between synthesis and metabolism of cholesterol in the frontal cortex of the AD brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14523054     DOI: 10.1194/jlr.M300320-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  100 in total

1.  Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease.

Authors:  Timothy M Hughes; Lewis H Kuller; Oscar L Lopez; James T Becker; Rhobert W Evans; Kim Sutton-Tyrrell; Caterina Rosano
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 2.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 3.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

4.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

5.  Sterol-dependent nuclear import of ORP1S promotes LXR regulated trans-activation of apoE.

Authors:  Sungsoo Lee; Ping-Yuan Wang; Yangsik Jeong; David J Mangelsdorf; Richard G W Anderson; Peter Michaely
Journal:  Exp Cell Res       Date:  2012-06-20       Impact factor: 3.905

6.  The antifungal drug voriconazole is an efficient inhibitor of brain cholesterol 24S-hydroxylase in vitro and in vivo.

Authors:  Marjan Shafaati; Natalia Mast; Olof Beck; Rima Nayef; Gun Young Heo; Linda Björkhem-Bergman; Dieter Lütjohann; Ingemar Björkhem; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2009-05-27       Impact factor: 5.922

Review 7.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

8.  Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients.

Authors:  Alana C Costa; Helena P G Joaquim; Valéria S Nunes; Daniel S Kerr; Guilherme S Ferreira; Orestes V Forlenza; Wagner F Gattaz; Leda Leme Talib
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-08-31       Impact factor: 5.270

9.  Endoplasmic reticulum stress mediates amyloid β neurotoxicity via mitochondrial cholesterol trafficking.

Authors:  Elisabet Barbero-Camps; Anna Fernández; Anna Baulies; Laura Martinez; Jose C Fernández-Checa; Anna Colell
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

Review 10.  Cholesterol-metabolizing cytochromes P450: implications for cholesterol lowering.

Authors:  Irina A Pikuleva
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-11       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.